AtriCure, Inc. (ATRC)
57.30
+1.49
(+2.67%)
USD |
NASDAQ |
Oct 12, 16:00
57.30
0.00 (0.00%)
After-Hours: 20:00
AtriCure Free Cash Flow (Quarterly) : 18.43M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.43M |
| March 31, 2026 | -7.848M |
| December 31, 2025 | 18.42M |
| September 30, 2025 | 24.11M |
| June 30, 2025 | 18.96M |
| March 31, 2025 | -13.21M |
| December 31, 2024 | 2.074M |
| September 30, 2024 | 16.40M |
| June 30, 2024 | 5.856M |
| March 31, 2024 | -24.65M |
| December 31, 2023 | 1.244M |
| September 30, 2023 | -2.108M |
| June 30, 2023 | -30.07M |
| March 31, 2023 | -6.641M |
| December 31, 2022 | -4.125M |
| September 30, 2022 | -6.929M |
| June 30, 2022 | 0.045M |
| March 31, 2022 | -28.01M |
| December 31, 2021 | -2.409M |
| September 30, 2021 | -1.736M |
| June 30, 2021 | -8.746M |
| March 31, 2021 | -10.64M |
| December 31, 2020 | 2.901M |
| September 30, 2020 | 2.519M |
| June 30, 2020 | -12.66M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.92M |
| December 31, 2019 | -7.886M |
| September 30, 2019 | -5.659M |
| June 30, 2019 | 0.998M |
| March 31, 2019 | -15.45M |
| December 31, 2018 | -0.098M |
| September 30, 2018 | 3.558M |
| June 30, 2018 | -2.322M |
| March 31, 2018 | -11.52M |
| December 31, 2017 | 0.229M |
| September 30, 2017 | -1.516M |
| June 30, 2017 | -2.817M |
| March 31, 2017 | -11.27M |
| December 31, 2016 | -0.829M |
| September 30, 2016 | -0.685M |
| June 30, 2016 | -7.562M |
| March 31, 2016 | -13.74M |
| December 31, 2015 | -9.238M |
| September 30, 2015 | -1.578M |
| June 30, 2015 | -0.129M |
| March 31, 2015 | -10.40M |
| December 31, 2014 | -6.831M |
| September 30, 2014 | -3.128M |
| June 30, 2014 | -5.43M |
| March 31, 2014 | -15.42M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 1.991B |
| Boston Scientific Corp. | 1.279B |
| AngioDynamics, Inc. | -18.48M |
| Alphatec Holdings, Inc. | -1.582M |
| Baxter International, Inc. | 166.00M |